David Einhorn
Greenlight Capital
David Einhorn DANIMER SCIENTIFIC INC-CW27 stake
total: 357
Greenlight Capital DNMRWS trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q2
According to 2026 Q2 report, David Einhorn doesn't hold any DANIMER SCIENTIFIC INC-CW27 (DNMRWS) shares. To date, the estimated cost basis is nearly $25.41 for "buy" trades and estimated average "sell" price is $25.41. Greenlight Capital first purchased DNMRWS in 2021 Q1, initially acquiring 27,233 shares. Since the initial investment in DANIMER SCIENTIFIC INC-CW27 (DNMRWS), Greenlight Capital has made 1 more transaction.
When did David Einhorn sell DANIMER SCIENTIFIC INC-CW27 (DNMRWS)?
David Einhorn sold off the entire DANIMER SCIENTIFIC INC-CW27 (DNMRWS) position in 2021 Q2.
When did David Einhorn buy DANIMER SCIENTIFIC INC-CW27 (DNMRWS)?
David Einhorn first invested in DANIMER SCIENTIFIC INC-CW27 (DNMRWS) in 2021 Q1 at the reported quarter-end price of $25.41 per share.
What's the cost basis of Greenlight Capital's DNMRWS stake?
The estimated cost basis for DANIMER SCIENTIFIC INC-CW27 (DNMRWS) stake is around $25.41 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $25.41
- Weighted AVG sell price:
- $25.41
David Einhorn's historical trades in DANIMER SCIENTIFIC INC-CW27
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q2
|
0.00%
|
0
|
$25.41
|
|
-100% (-27,233)
|
-0.05%
|
|
2021 Q1
|
0.05%
|
27,233
|
$25.41
|
$692,000
|
new
|
+0.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.